Hot Topic: Early Oral Cavity
This case-based panel discussion will provide a multidisciplinary approach to the management of early oral cavity cancer. The session outline the current evidence related to intraoperative management of the margins for the primary tumor resection and also emerging techniques that may impact show this is done in the future. Ddifferent approaches for management of the clinically N0 neck will also be discussed. Lastly, options for reconstruction following resection of early oral cavity tumors will be described.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Upon completion of this activity, participants should be able to do the following:
- Outline an evidence-based approach to margin assessment for early oral cancer.
- Determine appropriate options for management of cervical lymphatics for different types of early oral cancers.
- Recognize the importance of reconstruction in management of early oral cancer in order to optimize postoperative function.
Mike Moore, MD, is employed by Indiana University School of Medicine and is on the advisory board of Cancer Support Community and has a leadership position with Head and Neck Cancer Alliance.
Mike Varvares, MD, FACS, is employed by Massachusetts General Hospital and has no financial relationships with a commercial interest.
Margaret Brandwein-Weber, MD, is employed by Mount Sinai and has no financial relationships with a commercial interest.
Stephen Lai, MD, PhD, FACS, is employed by MD Anderson Cancer Center and is a consultant with Cardinal Health.
Eben Rosenthal, MD, is employed by Vanderbilt University receives research grants with the NIH and is a consultant with Vergent.
Kelly Malloy, MD, is employed by the University of Michigan and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.